Sorry, we do not have enough data to show an influence graph for this author.
- Full text PDF available (0)
- This year (0)
- Last 5 years (0)
- Last 10 years (2)
Journals and Conferences
PURPOSE Chemoimmunotherapy combining fludarabine, cyclophosphamide, and rituximab (FCR) is an active regimen for untreated patients with chronic lymphocytic leukemia (CLL) with 70% complete responses… (More)
Methods. Participants were 134 outpatients with type 2 diabetes who were under continuous care by four attending physicians at a university-affiliated hospital. The visit communication was recorded… (More)